These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36609359)

  • 1. Early urate-lowering therapy in gouty arthritis with acute flares: a double-blind placebo controlled clinical trial.
    Yang DH; Chen HC; Wei JC
    Eur J Med Res; 2023 Jan; 28(1):10. PubMed ID: 36609359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of acute and chronic gouty arthritis: present state-of-the-art.
    Schlesinger N
    Drugs; 2004; 64(21):2399-416. PubMed ID: 15481999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zhengqing fengtongning sustained-release tablets prevents gout flares in the process of ULT: A randomized, positive control, double-blind, double-simulation, multicenter trial.
    Jia E; Hu S; Geng H; Zhu H; Xie J; Xiao Y; Jiang Y; Xiao M; Zhang J
    Medicine (Baltimore); 2022 May; 101(18):e29199. PubMed ID: 35550468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylaxis of acute flares when initiating febuxostat for chronic gouty arthritis in a real-world clinical setting.
    Yu J; Qiu Q; Liang L; Yang X; Xu H
    Mod Rheumatol; 2018 Mar; 28(2):339-344. PubMed ID: 28485997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study.
    Yamanaka H; Tamaki S; Ide Y; Kim H; Inoue K; Sugimoto M; Hidaka Y; Taniguchi A; Fujimori S; Yamamoto T
    Ann Rheum Dis; 2018 Feb; 77(2):270-276. PubMed ID: 29102957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.
    Schlesinger N; Mysler E; Lin HY; De Meulemeester M; Rovensky J; Arulmani U; Balfour A; Krammer G; Sallstig P; So A
    Ann Rheum Dis; 2011 Jul; 70(7):1264-71. PubMed ID: 21540198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.
    Borstad GC; Bryant LR; Abel MP; Scroggie DA; Harris MD; Alloway JA
    J Rheumatol; 2004 Dec; 31(12):2429-32. PubMed ID: 15570646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of gouty arthritis.
    TALBOTT JH
    Calif Med; 1953 Sep; 79(3):220-6. PubMed ID: 13082423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should patients with interval gout be treated with urate lowering drugs?
    Fam AG
    J Rheumatol; 1995 Sep; 22(9):1621-3. PubMed ID: 8523333
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of chronic gouty arthritis: it is not just about urate-lowering therapy.
    Schlesinger N
    Semin Arthritis Rheum; 2012 Oct; 42(2):155-65. PubMed ID: 22542277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-hoc analysis of pegloticase pivotal trials in chronic refractory gout: relationship between fluctuations in plasma urate levels and acute flares.
    Mandell BF; Fields TR; Edwards NL; Yeo AE; Lipsky PE
    Clin Exp Rheumatol; 2021; 39(5):1085-1092. PubMed ID: 33427618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management and Cure of Gouty Arthritis.
    Keller SF; Mandell BF
    Rheum Dis Clin North Am; 2022 May; 48(2):479-492. PubMed ID: 35400373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma adsorption in refractory chronic gouty arthritis flare: A case report.
    Lei Y; Cui TJ; Wang XH; Zhang XM; Tang C; Zheng ZH
    Front Immunol; 2022; 13():1045982. PubMed ID: 36505444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chuanhu anti-gout mixture versus colchicine for acute gouty arthritis: a randomized, double-blind, double-dummy, non-inferiority trial.
    Wang Y; Wang L; Li E; Li Y; Wang Z; Sun X; Yu X; Ma L; Wang Y; Wang Y
    Int J Med Sci; 2014; 11(9):880-5. PubMed ID: 25013367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of hyperuricemia and gout].
    Pöllmann G; Kullich W; Klein G
    Wien Med Wochenschr; 1997; 147(16):382-7. PubMed ID: 9446417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating appropriate use of prophylactic colchicine for gout flare prevention.
    George M; Pullman-Mooar S; Hussain F; Schumacher HR
    Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1258-62. PubMed ID: 24376081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gouty Arthritis: A Review of Acute Management and Prevention.
    Wilson L; Saseen JJ
    Pharmacotherapy; 2016 Aug; 36(8):906-22. PubMed ID: 27318031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic approaches in the treatment of gout.
    Pillinger MH; Mandell BF
    Semin Arthritis Rheum; 2020 Jun; 50(3S):S24-S30. PubMed ID: 32620199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gout: nonsteroidal anti-inflammatory drugs and colchicine to prevent painful flares during early urate-lowering therapy.
    Kuritzky L; Panchal R
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):397-401. PubMed ID: 21133750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal anti-inflammatory drugs and colchicine to prevent gout flare during early urate-lowering therapy: perspectives on alternative therapies and costs.
    Peterson DM
    J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):402-4. PubMed ID: 21133751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.